Analyst Price Targets — MASI
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 17, 2026 2:44 pm | — | Stifel Nicolaus | $180.00 | $174.80 | TheFly | Masimo downgraded to Hold from Buy at Stifel |
| February 17, 2026 2:06 pm | Jason Bednar | Piper Sandler | $180.00 | $174.78 | TheFly | Masimo downgraded to Neutral from Overweight at Piper Sandler |
| December 5, 2025 11:11 am | — | Wells Fargo | $190.00 | $142.26 | TheFly | Masimo price target raised to $190 from $187 at Wells Fargo |
| December 4, 2025 12:23 pm | — | BTIG | $200.00 | $138.09 | TheFly | Masimo price target raised to $200 from $198 at BTIG |
| May 7, 2025 11:33 am | Marie Thibault | BTIG | $193.00 | $161.47 | TheFly | Masimo price target lowered to $193 from $206 at BTIG |
| December 18, 2024 1:46 pm | Jason Bednar | Piper Sandler | $210.00 | $170.63 | TheFly | Masimo price target raised to $210 from $180 at Piper Sandler |
| November 6, 2024 12:06 pm | Jayson Bedford | Raymond James | $170.00 | $150.71 | StreetInsider | Raymond James Upgrades Masimo Corp. (MASI) to Outperform |
| October 14, 2024 7:32 am | Marie Thibault | BTIG | $170.00 | $140.62 | TheFly | Masimo price target raised to $170 from $166 at BTIG |
| September 20, 2024 7:50 am | Jason Bednar | Piper Sandler | $165.00 | $114.61 | StreetInsider | Piper Sandler Reiterates Overweight Rating on Masimo Corp. (MASI) |
| June 3, 2024 5:01 am | Jason Bednar | Piper Sandler | $160.00 | $124.50 | TheFly | Masimo upgraded to Overweight from Neutral at Piper Sandler |
Latest News for MASI
Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner
IRVINE, Calif.--(BUSINESS WIRE)-- #Masimo--Masimo smartSET™-powered, AI-enabled OIRD detection has received FDA 510(k) clearance for the Radius VSM® wearable continuous patient monitor.
IART vs. MASI: Which Stock Should Value Investors Buy Now?
Investors interested in Medical - Instruments stocks are likely familiar with Integra LifeSciences (IART) and Masimo (MASI). But which of these two stocks presents investors with the better value opportunity right now?
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.